Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients

Introduction Risk stratification of severely ill patients remains problematic, resulting in increased interest in potential circulating markers, such as cytokines, procalcitonin and brain natriuretic peptide. Recent reports have indicated the usefulness of plasma DNA as a prognostic marker in various disease states such as trauma, myocardial infarction and stroke. The present study assesses the significance of raised levels of plasma DNA on admission to the intensive care unit (ICU) in terms of its ability to predict disease severity or prognosis. Methods Fifty-two consecutive patients were studied in a general ICU. Blood samples were taken on admission and were stored for further analysis. Plasma DNA levels were estimated by a PCR method using primers for the human beta-haemoglobin gene. Results Sixteen of the 52 patients investigated died within 3 months of sampling. Nineteen of the 52 patients developed either severe sepsis or septic shock. Plasma DNA was higher in ICU patients than in healthy controls and was also higher in patients who developed sepsis ( 192 ( 65 - 362) ng/ml versus 74 ( 46 - 156) ng/ml, P = 0.03) or who subsequently died either in the ICU ( 321 ( 185 - 430) ng/ml versus 71 ( 46 - 113) ng/ml, P < 0.001) or in hospital ( 260 ( 151 - 380) ng/ml versus 68 ( 47 103) ng/ml, P < 0.001). Plasma DNA concentrations were found to be significantly higher in patients who died in the ICU. Multiple logistic regression analysis determined plasma DNA to be an independent predictor of mortality ( odds ratio, 1.002 (95% confidence interval, 1.0 - 1.004), P = 0.05). Plasma DNA had a sensitivity of 92% and a specificity of 80% when a concentration higher than 127 ng/ml was taken as a predictor for death on the ICU. Conclusion Plasma DNA may be a useful prognostic marker of mortality and sepsis in intensive care patients.